A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
Celgene
M Domenica Cappellini; Vip Viprakasit; Ali T Taher; Pencho Georgiev; Kevin H M Kuo; Thomas Coates; Ersi Voskaridou; Hong-Keng Liew; Idit Pazgal-Kobrowski; G L Forni; Silverio Perrotta; Abderrahim Khelif; Ashutosh Lal; Antonis Kattamis; Efthymia Vlachaki; Raffaella Origa; Yesim Aydinok; Mohamed Bejaoui; P Joy Ho; Lee-Ping Chew; Ping-Chong Bee; Soo-Min Lim; Meng-Yao Lu; Adisak Tantiworawit; Penka Ganeva; Liana Gercheva; Farrukh Shah; Ellis J Neufeld; Alexis Thompson; Abderrahmane Laadem; Jeevan K Shetty; Jun Zou; Jennie Zhang; Dimana Miteva; Tatiana Zinger; Peter G Linde; Matthew L Sherman; Olivier Hermine; John Porter; Antonio Piga; BELIEVE Investigators